A Agilent Technologies Inc.

Agilent Innovation Again Recognized with Multiple Scientists' Choice Awards

(NYSE: A) has announced the receipt of three 2023 Scientists’ Choice Awards; Best New Spectroscopy Product of 2022, Analytical Science Video of the Year, Analytical Science Customer Service of the Year, and a Platinum Seal of Quality for their entire analytical HPLC systems. Announced on June 6th, 2023, at ASMS, these Scientists’ Choice Awards recognize the world’s most innovative and effective analytical science technologies, solutions, and focus on customers.

The Best New Spectroscopy Product of 2022 was awarded to the . The 6475 is a sensitive, robust, and versatile triple quadrupole mass spectrometer incorporating several technological advantages including the superheated Agilent Jet Stream (AJS) ion source, curved and tapered collision cell, heated hyperbolic quadrupoles, and ± 20 kV high-energy dynode detector system.

“We would like to thank our loyal customers for voting for the Agilent 6475 Triple Quadrupole LC/MS System,” said Ken Suzuki, vice president and general manager of Agilent’s Mass Spectrometry Division. “This is the latest evolution of our robust LC/MS/MS, incorporating instrument intelligence technologies such as early maintenance feedback, scheduled tune and check-tune, and intelligent secondary injection workflows that integrate seamlessly to help meet the challenges of our customers.”

The Analytical Science Video of the Year award was presented to Professor Detlef Knappe from North Carolina State University, in collaboration with Agilent, for his video .’ Discussing his work in analyzing contaminants in drinking water, Professor Detlef Knappe highlights how Agilent supported the development of the analytical methods he uses to identify and assess contaminants, including per- and polyfluoroalkyl substances (PFASs), enabling a better understanding of the routes of contamination and determining the potential safety of drinking water.

In recognition of the achievement of consistently receiving positive feedback from scientists around the globe via reviews on the SelectScience website, Agilent Technologies also received the Analytical Science Customer Service of the Year.

Additionally, based on the number of reviews and stars it has received on the Select Science website, Agilent also was awarded the SelectScience Platinum Seal of Quality for its which includes the 1220 Infinity II, 1260 Infinity II, 1260 Infinity II Prime, and the 1290 Infinity II LC systems.

“These multiple, top class SelectScience awards, as voted on by Agilent users and customers, recognize Agilent’s commitment to exemplary customer service, support, and innovation,” commented Sudharshana Seshadri, vice president of Agilent’s Mass Spectroscopy, Liquid Chromatography and Automation division. "Agilent has long played a role in helping our customers advance their research and testing, with our scientists and product managers developing some of the world's leading-edge technologies, and field engineers working side-by-side with customers, helping them to maximize their productivity. Together, we are bringing great science to life.”

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insights and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs 18,000 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, please subscribe to the Agilent . Follow Agilent on , and .

EN
03/07/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approva...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ , a recently approved CAR T therapy. Agilent's advanced cell analysis instrumentation, specifically the technology, was applied in developing and validating AUCATZYL. The xCELLigence RTCA technology supported the development and implementation of the potency assay. By providing precise and reliable cell analysis solutions, Agilent assisted Autolus in achieving the high standards required for FDA approval. Dr. Xiaobo Wang, Vice President and General Manager of the Cell Functio...

 PRESS RELEASE

CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital P...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Please replace the release with the following corrected version due to multiple revisions to the fifth paragraph. The updated release reads: AGILENT TO SHOWCASE NEXT-GENERATION DIGITAL PATHOLOGY SOLUTIONS AT USCAP 2025 (NYSE: A) is excited to announce its participation at the upcoming , which will be held March 22-27, 2025, in Boston. At the conference, Agilent will highlight innovative digital pathology solutions designed to enhance diagnostic accuracy and efficiency. In pathology, Agilent offers comprehensive tissue diagnostic solutions for analyzi...

 PRESS RELEASE

Agilent Research Catalyst Award Presented to Columbia University for P...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced that has received an Agilent Research Catalyst (ARC) Award on behalf of , an internationally recognized researcher and physician-scientist specializing in bone marrow transplant (BMT) and cancer cellular immunotherapy. Dr. Muranski is the Director of Cellular Immunotherapy Laboratory at Columbia University Irving Medical Center. He is also an Assistant Professor of Medicine at Columbia University Medical Center, a principal investigator at the Columbia Center for Translational Immunology (CCTI), and a member of the Herbert Irv...

 PRESS RELEASE

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Com...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced its kit has received two new companion diagnostic indications approvals under EU IVDR1, expanding the eligibility of treatment to early-stage non-small cell lung cancer (NSCLC) and previously untreated advanced melanoma patients. These two new indications bring the total indications launched in Europe for PD-L1 IHC 28-8 pharmDx to nine. PD-L1 IHC 28-8 pharmDx is approved for exclusive use with the advanced staining solution. Lung cancer and malignant melanoma are major healthcare concerns worldwide, with lung cancer accountin...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch